[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Integra LifeSciences Corporation\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":121},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,48,73,94],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":4},"100654863","urinary-bladder-matrix-ubm-registry-100654863",false,"NCT07805798","Urinary Bladder Matrix (UBM) Registry","Real-World Registry of Urinary Bladder Matrix","Inclusion Criteria\n\n* Adults aged ≥21 years at the time of initial urinary bladder matrix (UBM) product application.\n* Received or are receiving an eligible UBM product for treatment of a qualifying wound, including:\n\nPressure ulcer (Stage III\u002FIV) Necrotizing soft tissue infection (NSTI) Fournier's gangrene Pilonidal cyst Open abdomen Hidradenitis suppurativa Acute or chronic lower extremity wound Surgical incisional wound (retrospective cohort only)\n\n* For retrospective participants, medical records must contain sufficient source documentation to support data abstraction, including wound characteristics, UBM treatment information, and post-treatment outcome data.\n* For prospective participants, written informed consent must be obtained prior to any registry-related data collection, and the participant must be expected to remain available for follow-up through approximately 12 months after the index UBM application.\n\nExclusion Criteria\n\n* Wound treated with a skin substitute prior to UBM treatment.\n* Wound not treated with a UBM product.\n* Full-thickness (third-degree) burn wound.\n* Participation in another interventional clinical trial that, in the opinion of the investigator, may affect wound-healing outcomes.\n* Known terminal condition, limited life expectancy, inadequate medical records, or any other circumstance that, in the opinion of the investigator, would preclude meaningful participation in the registry or collection of adequate outcome data.","ALL","21 Years",{"count":19,"type":20},300,"ESTIMATED","12 Months","OBSERVATIONAL","The purpose of this registry is to collect real-world information on patients treated with Urinary Bladder Matrix (UBM) products. The study will evaluate patient characteristics, treatment patterns, and clinical outcomes to better understand how UBM products are used in routine clinical practice and the outcomes experienced by patients over time.",[25,26,27,28,29,30,31,32,33,34,35],"Tissue Repair","Soft Tissue Reconstruction","Wound Management","Pressure Ulcer (PU)","Necrotizing Soft Tissue Infection","Fournier's Gangrene","Pilonidal Cyst","Open Abdomen","Hidradenitis Suppurativa (HS)","Lower Extremity Wound","Incisional","NOT_YET_RECRUITING","2026-09-01",{"date":39,"type":40},"2026-09-04","ACTUAL",{"date":42,"type":20},"2026-08-31",{"date":44,"type":20},"2029-12-31",{"name":46,"class":47},"Integra LifeSciences Corporation","INDUSTRY",{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":4,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":55,"enrollmentInfo":56,"targetDuration":57,"studyType":22,"phases":4,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},"100598423","aera-pediatrics-registry-100598423","NCT07071298","AERA Pediatrics Registry","A Real World, Observational Pediatric Registry of the Acclarent AERA® Eustachian Tube Balloon Dilation System","Inclusion Criteria:\n\n1. Age \\\u003C18\n2. Specific indications for ETBD are documented\n3. ETBD with AERA device attempted-\n\nExclusion Criteria:\n\n1. ETBD with device other than AERA®\n2. Previous ETBD procedure-","18 Years",{"count":19,"type":20},"27 Months","Prospective, multi-center, observational, real-world evidence data collection registry to confirm the continued clinical performance of the AERA® device in pediatric patients",[60],"Dysfunction of Eustachian Tube",[62],"ETBD","RECRUITING","2026-07-06",{"date":66,"type":40},"2026-07-07",{"date":68,"type":40},"2025-06-17",{"date":70,"type":20},"2031-02",{"name":46,"class":47},9,{"id":74,"slug":75,"hasResults":11,"nctId":76,"briefTitle":77,"officialTitle":77,"acronym":78,"eligibilityCriteria":79,"healthyVolunteers":11,"sex":16,"minAge":55,"maxAge":4,"enrollmentInfo":80,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":82,"conditions":83,"keywords":4,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},"100400443","the-mirror-registry-minimally-invasive-intracerebral-hemorrhage-evacuation-100400443","NCT04494295","The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation","MIRROR","Inclusion Criteria:\n\n* Subject Age is \\> 18\n* Subject with a Head CT that demonstrates an acute, spontaneous, primary, supratentorial ICH of volume \\> 20 mL, assessed via standard of care techniques\n* Subject Surgery can be initiated within 24 hours of the last known well time or, in patients with wake-up onset, within 24 hours of the time the patient awoke with symptoms.\n* Subject has a NIHSS score \\> 5\n* Subject has a baseline Modified Rankin Scale (mRS) Score ≤ 2\n* Subject with a CT Angiography demonstrating no vascular malformation\n\nExclusion Criteria:\n\n* Subject has an underlying vascular lesion defined as causative source of ICH\n* Subject has a profound neurological deficit defined as fixed\u002Fdilated pupils or bilateral extensor motor posturing\n* Subject has an Infratentorial or brainstem ICH\n* Subject has a known life expectancy \\\u003C 6 months\n* Subject has an uncorrectable coagulopathy\n* Subject has a mechanical heart valve\n* Subject is pregnant\n* Subject participates in another concurrent interventional clinical trial\n* Subject who is unable to meet study follow-up requirements",{"count":81,"type":20},500,"This registry will study the use of the Aurora® Surgiscope to provide surgical access and visualization in minimally invasive removal of hematoma in the brain. Many methods of hematoma removal are available and will be based on surgeon preference. The impact of patient selection and time to surgery from last known well time will be explored.",[84],"Supratentorial Hemorrhage","2026-02-04",{"date":87,"type":40},"2026-02-06",{"date":89,"type":40},"2020-10-23",{"date":91,"type":20},"2029-10-15",{"name":46,"class":47},20,{"id":95,"slug":96,"hasResults":11,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":4,"eligibilityCriteria":100,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":101,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":103,"conditions":104,"keywords":106,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":112,"lastUpdatePostDateStruct":113,"startDateStruct":115,"completionDateStruct":117,"leadSponsor":119,"locationsCount":120},"100537339","bactiseal-catheter-safety-registry-study-100537339","NCT06276543","Bactiseal Catheter Safety Registry Study","A Multi-center, Retrospective Registry Study on the Safety of Bactiseal Catheter","Inclusion Criteria:\n\n1. The informed consent is exempted by the Ethics Committee of a research center. Or a subject or his\u002Fher legal representative signed the informed consent form (ICF) prior to the enrollment.\n2. A subject had an indication suitable to use Bactiseal Catheter.\n3. A subject implanted hydrocephalus shunt catheter for at least 2 years at the time of enrollment.\n\nExclusion Criteria:\n\n1. A subject didn't have an indication suitable to use the catheter.\n2. A subject was known to be allergic to a component or ingredient of the catheter to be implanted, including silicone catheter, rifampicin, and clindamycin.\n3. According to the comprehensive judgment of an investigator, a subject had an infection of the implant site when the shunt is implanted, such as ventriculitis, meningitis, peritonitis, and local implant skin infection.\n4. A subject was simultaneously implanted with another shunt catheter different from Bactiseal Catheter.\n5. A subject had a contraindication of the shunt operation.\n6. A subject had uncorrected coagulopathy or any bleeding disorder.",{"count":102,"type":20},200,"Research Purpose:\n\nThis study aims to continuously evaluate the safety of subjects implanted with a catheter (trade name: Bactiseal) produced by Integra LifeSciences Production Corporation. Device safety will be assessed based on all the adverse events that occurred within 2 years after implanted the catheter.\n\nResearch Design:\n\nThis study is designed to be single arm, multi-center, and retrospective. A total of 200 subjects will be retrospectively enrolled. Information will be collected on adverse events, including bacterial culture and drug resistance testing when infection (if done), of subjects enrolled within 2 years after the implantation of the Bactiseal Catheter between January 01, 2019 and June 30, 2022.\n\nThe following information will be collected from subjects' medical records or hospitals' databases (if any):\n\n1. General condition of the subjects (including previous shunting and external drainage operation)\n2. Intraoperative condition and catheter implantation\n3. Information on the shunt catheters\n4. Adverse events of subjects within 2 years after the operation and classification of the adverse events (except anticipated adverse events listed in section 8.1.2)\n5. Relevant examinations in case of postoperative infection, including bacterial culture and drug resistance testing (if done)",[105],"Hydrocephalus",[107,108,109,110,111],"hydrocephalus","cerebrospinal fluid","Shunt","antibiotic-impregnated catheter","infection","2025-01-23",{"date":114,"type":40},"2025-01-27",{"date":116,"type":40},"2024-09-29",{"date":118,"type":20},"2026-12-31",{"name":46,"class":47},8,""]